celastrol has been researched along with Ureteral Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Chen, X; Lin, C; Liu, T; Ren, L; Shan, W; Yang, Q; Zhang, H; Zhang, L; Zhang, X; Zheng, H | 1 |
| Cao, X; He, QH; Li, GQ; Li, SJ; Li, Y; Tang, M; Xu, GL; Zhang, K; Zhang, KQ; Zheng, QY | 1 |
2 other study(ies) available for celastrol and Ureteral Obstruction
| Article | Year |
|---|---|
Tubule-specific protein nanocages potentiate targeted renal fibrosis therapy.
Topics: Animals; Apoptosis; Cell Line; Disease Models, Animal; Epithelial Cells; Fibrosis; Kidney; Kidney Tubules; Male; Mice; Mice, Inbred BALB C; Pentacyclic Triterpenes; Rats; Rats, Sprague-Dawley; Ureteral Obstruction | 2021 |
Celastrol alleviates renal fibrosis by upregulating cannabinoid receptor 2 expression.
Topics: Animals; Camphanes; Disease Models, Animal; Fibrosis; Humans; Inflammation; Kidney; Kidney Diseases; Male; Mice, Inbred BALB C; Pentacyclic Triterpenes; Pyrazoles; Receptor, Cannabinoid, CB2; Signal Transduction; Smad3 Protein; Triterpenes; Up-Regulation; Ureteral Obstruction | 2018 |